Parabilis Medicines, Inc. carries a market capitalization of 95.09M, placing it among publicly traded companies globally.
| Market Cap | 95.09M |
| Enterprise Value | N/A |
Parabilis Medicines, Inc.'s stock has gained approximately 45.175% over the past 52 weeks. The 50-day moving average sits at 27.76, while the 200-day moving average is 27.76.
| Beta (5Y) | N/A |
| 52-Week Price Change | 45.175% |
| 50-Day Moving Average | 27.76 |
| 200-Day Moving Average | 27.76 |
| Average Volume (20 Days) | N/A |